论文部分内容阅读
目的:观察复方苦参注射液联合化疗治疗晚期非小细胞肺癌的临床疗效。方法:将80例晚期非小细胞肺癌患者随机分为治疗组和对照组各40例。两组均采用多西他赛联合卡铂(DC)方案治疗,治疗组同时应用复方苦参注射液。结果:治疗组近期总有效率为42.5%,优于对照组27.5%,有显著性差异(P<0.05),并有明显的缓解疼痛及减轻化疗毒副反应的作用。结论:复方苦参注射液联合化疗治疗晚期肺癌,可增强疗效,缓解疼痛,减轻化疗毒副反应,提高患者生存质量。
Objective: To observe the clinical effect of Compound Kushen Injection combined with Chemotherapy in the treatment of advanced non-small cell lung cancer. Methods: 80 patients with advanced non-small cell lung cancer were randomly divided into treatment group and control group, 40 cases each. Both groups were treated with docetaxel combined with carboplatin (DC) regimen, the treatment group also applied Compound Kushen injection. Results: The total effective rate in the treatment group was 42.5% in the recent period, which was significantly higher than that in the control group (27.5%) (P <0.05). The total effective rate of the treatment group was significantly relieved and alleviated the side effects of chemotherapy. Conclusion: Compound Kushen injection combined with chemotherapy for advanced lung cancer can enhance the curative effect, relieve pain, reduce chemotherapy side effects and improve patients’ quality of life.